Lexaria Bioscience (Lexaria Bioscience) Forward Dividend Yield % : 0.00% (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lexaria Bioscience Forward Dividend Yield %?

As of today (2024-06-19), the Forward Annual Dividend Yield of Lexaria Bioscience is 0.00%.

As of today (2024-06-19), the Trailing Annual Dividend Yield of Lexaria Bioscience is 0.00%.

LEXXW's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.69
* Ranked among companies with meaningful Forward Dividend Yield % only.

Lexaria Bioscience's Dividends per Share for the three months ended in Feb. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Lexaria Bioscience's Forward Dividend Yield %

For the Biotechnology subindustry, Lexaria Bioscience's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexaria Bioscience's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexaria Bioscience's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Lexaria Bioscience's Forward Dividend Yield % falls into.

Lexaria Bioscience Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Lexaria Bioscience (NAS:LEXXW) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Lexaria Bioscience Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Lexaria Bioscience's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexaria Bioscience (Lexaria Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexaria Bioscience Corp (NAS:LEXXW) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

LEXX:USA

Address

740 McCurdy Road, Suite 100, Kelowna, BC, CAN, V1X 2P7

Website

https://www.lexariabioscience.com

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.